Introduction {#Sec1}
============

Viruses, like all obligate intracellular pathogens, have to find the means to cross cellular membranes. This is the key to initiating their infectious cycle, and involves a number of discrete steps like receptor binding and entry, capsid destabilization and genome uncoating, culminating in the release of viral nucleic acids at their site of replication. Many of these changes result from conformational alterations in metastable viral structures. Virus binding to and/or cross-linking their specific receptors can also lead to activation of downstream signaling events (Greber [@CR39]). These signals often induce changes that promote entry, prepare the cell for invasion and neutralize host defences. In animal cells, enveloped viruses achieve entry in two principal ways: (1) by direct fusion with the plasma membrane, or (2) by an internalization process into endosomes. For viruses using the first strategy, fusion between the viral and cellular membranes occurs after receptor docking and before the virus core penetrates the cell. Recent developments in membrane trafficking have demonstrated the existence of multiple endocytic pathways at the plasma membrane (Marsh and Helenius [@CR55]). Indeed, most viruses prefer to enter cells via endocytosis since the endocytic network confers an additional advantage of specific localization within the cell for a successful infection. In the case of endocytic entry, the virus must penetrate or fuse with the endosomal membrane to be released into the cytoplasm. Studies indicate that endocytosis serves as an entry portal for both enveloped and non-enveloped viruses. While there have been many advances in understanding how enveloped viruses achieve membrane fusion, the penetration mechanisms of most non-enveloped viruses still lack clarity. This review will give an update on the viral entry pathways and highlight the common themes and key differences between the strategies deployed by enveloped and non-enveloped viruses to achieve productive cell entry.

Role of attachment factors {#Sec2}
==========================

In a typical animal virus, the nucleic acid is condensed in an icosahedral or helical nucleoprotein complex called capsid. Enveloped viruses bud through cellular membranes and as a result the nucleocapsid is surrounded by an additional lipid bilayer. The cellular membrane is modified by the virus and contains viral glycoproteins that appear as spikes on the surface of the virus particle. Many viruses also carry accessory protein molecules that aid in infection, like reverse transcriptase, RNA polymerase, kinases, etc. In addition, viruses also incorporate host cellular proteins into or onto newly formed particles. This could be due to specific interactions between viral and cellular proteins during virus assembly, or even the presence of cellular membrane proteins in the immediate vicinity of virus budding from cells. Host cell proteins commonly incorporated into virions are Tsg101 and other proteins of the multi-vesicular body pathway that are involved in viral egress, APOBEC3G, a protein of the RNA editing machinery, cyclophilins, etc. Cyclophilin A is involved in T-cell activation and is thought to provide a chaperone function, is incorporated in many viruses like HIV-1, vaccinia virus and vesicular stomatitis virus (VSV) (Cantin et al. [@CR15]). Studies have shown that HIV infectivity is finely tuned by the expression levels of host Cyclophilin A. There also exist multiple host membrane proteins that are inserted in mature virions. The HIV particle contains proteins like MHC-I, MHC-II, ICAM-1, cytoskeleton-associated proteins like actin, ezrin, moesin and cofilin, and glycosylphosphatidylinositol (GPI)-linked proteins Thy-1 and CD59 (Cantin et al. [@CR15]). Many of these proteins enhance receptor binding efficacy and kinetics and thus play a crucial role in determining the efficiency of infection.

For the majority of viruses, the initial stage of the entry process is the binding of a viral attachment protein to a generalized receptor, followed by interaction with a more specific host cell receptor. These generalized receptors, more commonly known as attachment factors, concentrate virus particles on the host cell and create conditions favourable for receptor binding. The molecules to which viruses bind constitute a diverse collection of cellular proteins, carbohydrates and lipids, and play an important role in viral entry (Lonberg-Holm and Philipson [@CR51]). Heparan sulfate proteoglycans (HSPGs) serve as attachment factors for a large number of viruses (Bernfield et al. [@CR9]) that include include the herpes simplex virus (WuDunn and Spear [@CR99]), vaccinia virus (Chung et al. [@CR20]), flaviviruses such as the dengue virus (Chen et al. [@CR19]) and hepatitis C virus (HCV) (Barth et al. [@CR5]), retroviruses such as the human immunodeficiency virus (HIV) (Mondor et al. [@CR60]) and T-cell leukemia virus (Pinon et al. [@CR72]), as well as non-enveloped viruses like adeno-associated virus (Dechecchi et al. [@CR23]), papillomavirus (Giroglou et al. [@CR36]) and norovirus (Tamura et al. [@CR91]). Recent studies from our own laboratory have also shown the non-enveloped hepatitis E virus to attach to hepatic cells through HSPGs (Kalia et al. [@CR101]).

The HSPGs are present almost ubiquitously on cell surfaces but are extensively heterogenous with respect to their composition and quantity among different species, cell types, tissues and developmental stages. These variations include modifications in the length, degree of sulfation, and positions of the sulphate groups in the disaccharide repeats (Lindahl et al. [@CR50]). In many cases, the binding of a particular ligand to heparan sulfate (HS) depends on its specific sulfation pattern (Lyon and Gallagher [@CR52]). It has been proposed that the tissue tropism of some viruses may be determined by the heparan sulphate fine structure (Shukla et al. [@CR83]). Many viruses also bind to sialic acid containing groups (Olofsson and Bergstrom [@CR63]), for which the key examples include the influenza virus (Skehel and Wiley [@CR86]), coronaviruses (Schwegmann-Wessels and Herrler [@CR82]) and non-enveloped viruses like orthoreoviruses (Guglielmi et al. [@CR40]) and rotavirus (Isa et al. [@CR45]). Gangliosides (GM1, GD1a and GT1b) are well established attachment factors for non-enveloped polyoma viruses like SV40 (Tsai et al. [@CR92]). Viruses like HIV, dengue virus, HCV and Ebola virus have high mannose N-linked glycans in their envelope glycoproteins, which can bind cell surface lectins such as DC-SIGN and L-SIGN (Feinberg et al. [@CR26]; Pohlmann et al. [@CR75]; Simmons et al. [@CR85]). DC-SIGN is highly expressed on dendritic cells present in mucosal tissues and binds to the HIV-1 envelope glycoprotein gp120 to efficiently capture the virus in the periphery. This facilitates HIV-1 transport to secondary lymphoid organs that are rich in T cells, to enhance infection in *trans* of these target cells (Geijtenbeek et al. [@CR34]).

The individual interaction between a virus and a single attachment factor or receptor can be weak and relatively non-specific (Skehel and Wiley [@CR86]), but serves the purpose of concentrating viruses on the specific host cells. Multiple binding leads to increased avidity, and this makes virus binding virtually irreversible.

Receptor binding {#Sec3}
================

Following attachment, receptor binding is often the second and more critical step in viral infection. Cellular receptors vary from one virus to the next and are in many cases cell specific. Viruses from the same family can have selectivity for different receptors, while viruses from different families can use the same protein as their cellular receptor. An example of this is the coxsackie-adenovirus receptor (CAR) protein, which is an immunoglobulin superfamily cell surface protein that is used by coxsackie virus, a RNA virus belonging to family *Picornaviridae* and adenovirus, a DNA virus of the family *Adenoviridae*. The presence of receptors determines to a large extent the tissue and species tropism of the virus. Viruses with a high mutation rate can switch receptors or adapt to use alternate receptors when the primary receptor is absent (Vlasak et al. [@CR94]).

Integrins are prime examples of physiologically important receptors that have been exploited by enveloped and non-enveloped viruses alike for attachment and/or cell entry. Many, but not all integrins recognize RGD sequences displayed on the exposed loops of viral capsid proteins or extracellular matrix proteins. A striking feature of the interaction of non-enveloped viruses with integrins is that this often involves very similar geometry or spacing of receptor engagement around the five-fold axis of the virion (Stewart and Nemerow [@CR88]). Virus binding can induce clustering and/or conformational changes in integrin quaternary structure and elicit cell-signaling events that increase ligand affinity as well as promote cytoskeletal rearrangement and virus internalization. Viruses that bind integrins include the human cytomegalovirus (Feire et al. [@CR27]), hantavirus (Gavrilovskaya et al. [@CR33]), adenovirus (Wickham et al. [@CR98]), rotavirus (Graham et al., [@CR37]), echovirus-1 (EV-1) (Evans and Almond [@CR25]) and several other picornaviruses like coxsackie virus, foot and mouth-disease virus, etc. The HIV-1 envelope glycoprotein gp120 was recently shown to bind to activated integrin α~4~β~7~ that is preferentially expressed on gut CD4^+^ T cells. This results in activation of LFA-1, the key integrin involved in establishment of virological synapses, and enables efficient spread of HIV-1 leading to massive depletion of gut CD4+ cells (Arthos et al. [@CR3]).

Apart from integrins, there are numerous other cell surface molecules that act as viral receptors. Receptor binding leads to uptake of virus, most often into endosomes and also triggers signaling events in the cell. It also serves as a cue that induces conformational changes necessary for membrane fusion and penetration. Some viruses use multiple attachment factors and receptors in parallel or in succession. In enveloped viruses, the spike glycoproteins play a role as membrane fusion factors and/or receptor destroying enzymes. Specific examples of this are the hemagglutinin of influenza virus with bound sialic acid (Skehel and Wiley [@CR86]) and the gp120 of HIV-1 bound to CD4 (Kwong et al. [@CR49]). After gp120 binding CD4 and the coreceptor (CXCR4 or CCR5), the ectodomain of the fusogenic gp41 peptide undergoes a conformational change leading to its activation. This initiates membrane fusion by exposing a hydrophobic N-terminal core of the trimeric gp41 (Furuta et al. [@CR30]). The activity of the gp41/gp120 complex is precisely regulated. At the level of its amino acid sequence, gp41 shares many features with other viral envelope glycoproteins involved in membrane fusion. In non-enveloped viruses, projections or indentations on the capsid surface are the receptor binding domains. Adenoviruses have prominent homotrimeric fibres with globular knobs that project from each of the 12 vertices. The X-ray crystal structure of the adenovirus knob, together with the N-terminal domain of the coxsackie and adenovirus receptor (CAR), shows a large contact area on the lateral side of each subunit in the knob (Bewley et al. [@CR10]). The penton base of many adenovirus subfamilies contains an exposed RGD sequence that associates with integrins (Stewart et al. [@CR89]). In rhinoviruses and entroviruses, including the poliovirus, the receptors bind in a cleft in the capsid surface called the "canyon" (Rossmann et al. [@CR78]). For some viruses, binding may cause destabilization of the particle, which is the first step towards uncoating.

Endocytic routes for virus internalization {#Sec4}
==========================================

Although some viruses release their genomes into the cell by direct fusion with the plasma membrane, most viruses enter cells via endocytosis (Pelkmans and Helenius [@CR67]). Several viruses like murine leukaemia virus, avian leucosis virus, HIV and VSV use the cortical actin cytoskeleton, together with myosin II, for directed movement along microvilli or filopodia towards endocytic 'hot spots' on the cell.

Multiple endocytic pathways simultaneously operate at the cell surface and differ in their mechanism of formation, molecular machinery and cargo destination (Fig. [1](#Fig1){ref-type="fig"}). Endocytic compartments are dynamic structures that undergo complex trafficking and sorting events, which are regulated by inherent signals on the internalized receptor, membrane composition and signaling events. After internalization, virus particles are sequestered in endocytic organelles until the proper conditions are met for release of the viral genome. Endosomes offer a convenient and often rapid transit system across the plasma membrane and through a crowded cytoplasm via the cellular microtubular network. It also provides protection to the virus from detection by the host's innate immune defences. For viruses that replicate in the nucleus, the endosome can deliver its viral cargo to the vicinity of the nuclear pore, ready for translocation into the nucleoplasm (Whittaker and Helenius [@CR97]).Fig. 1Multiple endocytic pathways operate at the plasma membrane and are utilized in viral entry. The clathrin coated pit pathway is the best characterized endocytic pathway and is used for entry by many viruses like the influenza virus, the herpes simplex virus (HSV), HIV-1, adenovirus and poliovirus. The induced caveolar pathway is the main entry portal for polyomaviruses like SV40 and echovirus. Many viruses are also internalized by clathrin and caveolin independent pathways, which are still not well understood in terms of cargo specificity and molecular players. Though the cartoon shows influenza virus, HSV, poliovirus and SV40 virus internalization via a clathrin and caveolin independent pathway, the independent pathway utilized by one virus may differ from that used by another virus. Macropinocytosis is triggered by virus binding and utilized by vaccinia virus and adenovirus

For many enveloped viruses a low pH in the sorting/late endosome is the trigger for conformational changes necessary to initiate membrane fusion events leading to release of the viral genome at its replication site. This is well established for influenza virus, VSV and the Semliki Forest virus (Gaudin et al. [@CR32]). Among non-enveloped viruses, several families, including picornaviruses and polyomaviruses do not require a low pH for penetration (Hogle [@CR44]).

Viruses in turn have also served as important tools to understand the functioning of endocytic pathways. Together with rapid advances in high-resolution and multicolour live cell imaging techniques, our understanding of viral entry pathways and interactions between viral and cellular structures has substantially improved. We present here a brief overview of the major endocytic pathways operating in mammalian cells and their exploitation by viruses to gain access into cells.

Clathrin coated pit pathway {#Sec5}
---------------------------

Clathrin-mediated endocytosis is considered to be the major pathway for receptor internalization in metazoans, and a large array of protein and lipid interactions have been deciphered (Sorkin [@CR87]). This pathway can mediate the constitutive uptake of ligands such as transferrin and low-density lipoprotein (LDL) as well as ligand-triggered uptake of receptor proteins such as the epidermal growth factor receptor. New imaging technologies have provided a real-time, detailed view that allows a deeper understanding of clathrin-mediated endocytosis (Merrifield et al. [@CR59]). Clathrin and associated proteins assemble on the intracellular face of the plasma membrane to form invaginations that pinch off through the action of the large GTPase dynamin. The clathrin-coated pit (CCP) endocytic pathway (Fig. [2](#Fig2){ref-type="fig"}) is an equally important gate for entry of many viruses and transports viruses together with their receptors into early endosomes (Brodsky et al. [@CR14]). As they mature into early endosomes, clathrin-coated vesicles shed their protein coat and become acidified (Fig. [2](#Fig2){ref-type="fig"}). Early endosomes are major sorting stations for internalized cargo, which can be recycled to the plasma membrane or progress to late endosomes and subsequently to lysosomes. Depending upon the pH threshold, the site of penetration can be at the early or late endosomes. Several viruses, including influenza virus and VSV have been identified in clathrin-coated vesicles by electron microscopy (Marsh and Helenius [@CR55]). Many non-enveloped viruses also use the CCP pathway for entry and infection. Well-studied examples include the reovirus, which in common with influenza virus enters by *de novo* formation of CCPs, poliovirus, which was observed in coated vesicles by electron microscopy (Zeichhardt et al. [@CR100]) and human adenoviruses, which replicate and produce progeny virions within the nucleus of an infected cell. Parvoviruses, which are among the smallest animal DNA viruses also enter cells via the CCP. The infection by canine parvovirus (CPV) and adeno-associated virus type 2 (AAV2) was inhibited by over-expression of a dominant negative mutant (K44A) of dynamin 2, and by treatment with lysosomotropic agents, including ammonium chloride and bafilomycin A, suggesting the involvement of the CCP pathway to late endosomes/lysosomes (Bartlett et al. [@CR6]; Basak and Turner [@CR7]; Parker and Parrish [@CR64]). Shortly after uptake, CPV capsids colocalize with transferrin in perinuclear recycling endosomes (Parker and Parrish [@CR64]). The incoming viruses are exposed to the acidic milieu of endosomes within minutes and many respond to the pH drop by undergoing changes that lead to acid-dependent disruption of the endosomal membrane. In some cases, such as for the Ebola virus, the SARS coronavirus, and the nonenveloped mammalian reoviruses, acidic pH alone is not sufficient to induce fusion. In these cases, proteolytic cleavage of viral proteins by endosomal proteases is also required to make the virus penetration-competent (Chandran et al. [@CR18]; Ebert et al. [@CR24]).Fig. 2Entry of a pH dependent enveloped virus. Many viruses are endocytosed via a clathrin-dependent pathway into clathrin coated pits. The clathrin coat is rapidly lost inside the cell and the vesicle matures into an early endosome. The acidic pH of the endosome brings about a conformational change in the viral envelope protein leading to fusion of the viral and endosomal membranes and capsid release into the cytosol. Genome release often occurs close to the viral replication centre. After capsid disassembly the viral RNA can initiate the replication cycle

Caveolar Pathway {#Sec6}
----------------

The caveolar pathway is a well characterized entry portal for the non-enveloped simian virus 40 (SV40) (Pelkmans and Helenius [@CR66]), mouse polyomavirus (Richterova et al. [@CR76]) and EV-1, a picornavirus that binds to integrins (Pietiainen et al. [@CR71]). Though this endocytic route is dynamin and cholesterol dependent, compared to clathrin-mediated entry, internalization of caveolae is much slower and the resulting vesicles do not become acidified. The caveolar pathway takes the majority of internalized viruses to pH neutral organelles called caveosomes from where cargo is sorted depending upon specific cues (Pelkmans et al. [@CR69]).

Caveolae are also known to be the major signal initiating centres within the cell (Ceresa and Schmid [@CR16]). As a result viruses that utilize this pathway also activate signaling in cells. For example, EV-1 utilizes integrins α2β1 as the entry receptor. Virus binding leads to cross-linking of the integrin complexes, its re-localization to caveolae and subsequent internalization in a protein kinase c-dependent manner (Marjomaki et al. [@CR54]; Upla et al. [@CR93]). Exogenously added glycosphingolipids can activate c-Src resulting in caveolin-1 phosphorylation and increased caveolar dynamics. Viruses like SV40 can stimulate c-Src at the site of glycosphingolipid crosslinking, by locally increasing the concentration of GM1. Thus c-Src plays an important role for SV40 internalization and infection (Pelkmans et al. [@CR70]). RNAi silencing screens for the entire human kinome have demonstrated the involvement of nearly 80 kinases in caveolar endocytosis in HeLa cells (Pelkmans et al. [@CR70]). Many of these kinases are also known to regulate integrin signaling and actin dynamics. Only a partial overlap was observed between the kinases involved in caveolar endocytosis versus those involved in clathrin mediated uptake of VSV, highlighting the complexity of these processes.

Clathrin and dynamin Independent pathways {#Sec7}
-----------------------------------------

Recent studies on the mechanisms of endocytosis have revealed a startling diversity of ways by which membrane proteins and lipids are internalized from the surface of eukaryotic cells. In addition to the classical receptor-dependent endocytic mechanisms, many pathways that do not utilize the clathrin/caveolar-coat or the ubiquitous dynamin GTPAse for vesicle detachment have been discovered (Nichols and Lippincott-Schwartz [@CR61]; Sabharanjak et al. [@CR80]). The entry of many viruses is implicated to occur through these pathways, based mainly on the presence of viruses in non-coated vesicles by electron microscopy (Marsh and Helenius [@CR55]). In addition, many viruses can exploit several endocytic pathways, enabling them to infect a wide range of cells under various conditions, the well studied examples of this kind being SV40 (Damm et al. [@CR22]), herpes simplex virus (Nicola and Straus [@CR62]) and the influenza virus (Sieczkarski and Whittaker [@CR84]). Direct visualization in a virus tracking experiment has shown the entry of influenza viruses simultaneously in two pathways. Whereas most viruses are internalized through clathrin-mediated endocytosis by promoting the de novo formation of clathrin-coated pits at the viral binding site, the remaining virus particles enter through a clathrin- and caveolin-independent pathway (Rust et al. [@CR79]).

A novel endocytic pathway involved in the endocytosis of GPI-anchored proteins (GPI-APs) and a bulk of the fluid phase in the cell has been described (Kalia et al. [@CR47]; Sabharanjak et al. [@CR80]). Endosomes of GPI-APs and fluid, also called GEECs (GPI-AP enriched early endosomal compartments) are generated from primary endocytic events and are more acidic than sorting endosomes derived from the clathrin-coated pit pathway. The GEECs ultimately deliver their contents to sorting endosomes. This pathway is also the major route of uptake of cholera toxin by the cell (Kalia et al. [@CR47]). Studies suggest that the GEEC pathway could represent a key pathway for diverse functions across phyla. It would be interesting to see if this pathway is also exploited by viruses for entry into cells. A recent study showed that a majority of the echoviruses enters via a fluid phase pathway (Karjalainen et al. [@CR48]), but the molecular players of the pathway remain to be characterized. Our initial studies using fluorescently labelled hepatitis E virus like particles have shown that a majority of the particles co-localize with fluid endosomes, but show no overlap with sorting endosomes marked with transferrin, indicating internalization via a clathrin-independent pathway (MK, unpublished data).

Macropinocytosis {#Sec8}
----------------

Macropinocytosis is generally considered to be a non-specific mechanism for internalization that is primarily driven by actin. It occurs in response to cell stimulation when large folds of the plasma membrane fuse back to form huge endosomes. The finding that macropinosomes can become acidified and intersect with sorting vesicles (Hewlett et al. [@CR43]), makes them possible routes of entry for a wide variety of viruses. Vaccinia virus can activate p21-activated kinase 1 (PAK1) leading to macropinocytosis and viral entry (Mercer and Helenius [@CR58]). A recent study on adenovirus has shown integrin-dependent virus binding leading to activation of macropinocytosis and virus internalization into macropinosomes (Amstutz et al. [@CR2]). Macropinocytic uptake of HIV-1 into macrophages has been demonstrated, however most of the virions internalized this way were found to be degraded (Marechal et al. [@CR53]).

The presence of multiple pathways and previously unobserved endocytic organelles challenges established assumptions about the entry of many viruses. It was recently observed that influenza virus, which was thought to enter by the clathrin-coated pit pathway (Matlin et al. [@CR56]), can also infect cells in which the clathrin-coated vesicle transport was blocked (Sieczkarski and Whittaker [@CR84]). The electron microscopic visualization of many viruses in non-coated vesicles is also indicative of the presence of non-clathrin pathways. The GM1-associated virus, SV40 is also efficiently internalized in a dynamin and clathrin-independent manner in fibroblasts derived from caveolin-1 knockout mice (Damm et al. [@CR22]). Studies have also shown that polyomavirus can enter cells via a non-clathrin, non-caveolin and dynamin independent pathway (Gilbert and Benjamin [@CR35]). More studies will reveal whether the clathrin-independent pathways used by influenza virus, SV40 and polyomavirus are similar or different in terms of their regulation. Recent studies have revisited poliovirus and have shown that clathrin-mediated endocytosis is not essential for its entry into cells. Live cell imaging studies in HeLa cells found poliovirus to enter cells through a clathrin-, caveolin-, flotillin-, and microtubule-independent, but tyrosine kinase- and actin-dependent endocytic mechanism (Brandenburg et al. [@CR13]). This study demonstrates that uncoating of the poliovirus capsid does not occur on the cell surface as previously believed, but within the cell. In another study, poliovirus entry into human brain microvascular endothelial cells found that though uncoating was found to occur inside the cell, virus entry depended on both caveolin and dynamin, and the virus was detected in caveolin-containing vesicles within the cytoplasm (Coyne et al. [@CR21]). It thus seems likely that poliovirus uses different mechanisms as it enters different cell types. As the cellular entry of more viruses is characterized, this may be more a rule than an exception. The cellular context is likely to play a determining role in the entry pathway a virus takes in a given cell type.

Genome release for enveloped and non-enveloped viruses {#Sec9}
======================================================

The mechanisms of genome release are widely different between enveloped and non-enveloped viruses because of different surface compositions. Enveloped viruses fuse with the plasma or endosome membranes, thereby exposing the genome or capsid to the cytosol, whereas non-enveloped viruses partially disrupt membranes to release viral nucleic acids. Many viruses require the low pH environment in the endosome to trigger a conformational change in the viral glycoprotein that leads to the exposure and insertion of the fusion peptide into the cellular membrane.

Viral Glycoprotein mediated membrane fusion {#Sec10}
-------------------------------------------

Emerging single-virus tracking experiments have also aided in understanding the fusion mechanisms of enveloped viruses in live cells. Enveloped animal viruses employ membrane fusion to enter the cytoplasm, and this process is mediated by the viral surface proteins. For many viruses the envelope glycoproteins are synthesized as "inactive" precursors that undergo proteolytic cleavage to become fully active. After binding to the receptor, a conformational change, sometimes pH triggered, is necessary to expose a hydrophobic "fusion-peptide", which inserts into the cell membrane and mediates the fusion of viral and cellular membranes (Jahn et al. [@CR46]; Peisajovich and Shai [@CR65]). Viral glycoproteins are thus classified as pH independent or pH dependent based on the trigger required to activate their membrane fusion potential. Enveloped viruses like herpes simplex virus 1 (HSV-1), Sendai virus and retroviruses like HIV-1 have pH independent fusion proteins and can penetrate cells by direct fusion at the plasma membrane. The primed and triggered conformational changes in the fusion proteins result in close apposition of the viral and cellular bilayers, membrane merger, and cytoplasmic delivery of the viral nucleocapsid. Well-studied proteins of this category are the influenza virus hemagglutinin (HA), and the tick-borne encephalitis virus (TBEV) E protein (Skehel and Wiley [@CR86]) and the Ebola virus glycoprotein (Chandran et al. [@CR18]). Fusion appears to be driven, in many cases, by a coiled-coiled structure intimately involved with the conformational changes that accompany the process (Matthews et al. [@CR57]). A number of studies have been carried out on viral envelope glycoproteins, including their X-ray crystal structure determination (Heldwein et al. [@CR41]; Roche et al. [@CR77]). Amongst the best characterized membrane fusion mechanisms are those of the influenza virus whose integral membrane protein M2 forms pH-gated proton channels in the viral lipid envelope (Pinto et al. [@CR74]). The low pH of an endosme activates the M2 channel before haemagglutinin-mediated fusion. Proton influx leads to acidification of the viral interior facilitating dissociation of the matrix protein from the viral nucleoproteins---a step required for unpacking of the viral genome (Helenius [@CR42]). Inhibiting the proton conductance of M2 using the anti-viral drugs amantadine or rimantadine inhibits viral replication (Pinto et al. [@CR74]). The structure of the tetrameric M2 channel in complex with rimantadine, an anti-viral drug that inhibits proton conductance of M2, has recently been determined by NMR (Schnell and Chou [@CR81]). In the closed state, four tightly packed transmembrane helices define a narrow proton channel with a 'tryptophan gate' locked by intermolecular interactions with aspartic acid. The transmembrane helical packing destabilizes on lowering the pH and opens to allow proton influx through water. The NMR study suggests that rimantadine binds at four equivalent sites near the gate and stabilizes the closed conformation of the pore and thus works as an anti-viral drug. The discovery of an external drug-binding site was unexpected since earlier studies had suggested that drug-binding site is lined by residues that are mutated in drug-resistant viruses (Grambas et al. [@CR38]; Pinto and Lamb [@CR73]). The authors suggest that drug-resitant mutants either increase the hydrophilicity of the pore or weaken helix-helix packing, that leads to channel opening. However, in sharp contrast, another X-ray crystallography study on the M2 channel in the presence and absence of the drug amantadine shows the channel to be open with helices spreading out on the cytoplasmic side to widen the Tryptophan gate, and a single amantadine molecule plugging the open pore (Stouffer et al. [@CR90]). In the open structure, four critical amino-acid residues project side chains into the pore near the amantadine binding site, and it is predicted that these substitutions will impare drug binding and hence inhibition.

Penetration by non-enveloped viruses {#Sec11}
------------------------------------

Whereas a detailed understanding of the entry process and fusion mechanisms are available for many enveloped viruses, much less is know about the entry of non-enveloped viruses. Because these viruses do not have a membrane, the entry mechanism cannot involve membrane fusion, but, capsid-dependent mechanisms for penetrating the cell membrane or lysing endosomes are likely to be involved. Many studies indicate that penetration of non-enveloped viruses also involves cooperative changes in virus particles triggered by receptor binding or low pH (Hogle [@CR44]; Rossmann et al. [@CR78]). Most non-enveloped virus capsid proteins have short, membrane altering, amphiphatic or hydrophobic sequences that mediate membrane penetration (Banerjee and Johnson [@CR4]). These "penetration proteins" may undergo primed and triggered conformational transitions that allow them to interact with membranes. Adenovirus particles exposed to low pH undergo a conformational change in the penton base that renders the particle hydrophobic and capable of permeabilizing liposomes (Blumenthal et al. [@CR11]).

The entry mechanism of poliovirus, the best-characterized member of the family *Picornaviridae*, has been examined in much detail. On receptor binding, the poliovirus capsid undergoes conformational rearrangements, exposing the N-termius of the capsid protein VP1 and the myristoylated autoclevage peptide VP4, which can insert into liposomes (Belnap et al. [@CR8]; Fricks and Hogle [@CR29]). These newly exposed sequences are then thought to form a transmembrane pore through which the genomic RNA may be extruded into the cytoplasm (Hogle [@CR44]). The reovirus protein μ1 is found in virions mostly as autolytic fragments μ1N and μ1C, which participate directly in membrane penetration during virus entry into cells (Agosto et al. [@CR1]; Chandran et al. [@CR17]). The bluetongue virus, another member of the non-enveloped *Reoviridae* family, has two capsid proteins, a receptor-binding protein, VP2, and a second protein, VP5, which shares structural features with class I fusion proteins of enveloped viruses. The VP5 can undergo pH-dependent conformational changes that render it capable of interacting with cellular membranes (Forzan et al. [@CR28]). Non-enveloped Nodaviruses, like the flockhouse virus have a unique capsid protein associated to a gamma peptide of 44 residues, which results from the self-clevage of a capsid protein precursor (Wery et al. [@CR96]). The gamma peptide has a lipid-binding domain and can permeabilize biological membranes allowing genome translocation through the membrane (Banerjee and Johnson [@CR4]; Bong et al. [@CR12]). One of the four structural peptides, pep46, a 46-amino acid amphiphilic peptide of the infectious bursal disease virus deforms synthetic membranes and induces pores with a diameter of less than 10 nm, which are visualized by cryoelectron microscopy (Galloux et al. [@CR31]).

Virus induced signaling {#Sec12}
=======================

To prepare a cell for the invasion, virus particles can trigger intracellular events as soon as they bind to the plasma membrane. This generally involves the binding to and the cross-linking of cell-surface molecules such as glycosphingolipids, receptor tyrosine kinases and integrins. Initiation of signaling at the cell surface leads to the propogation of a downstream cascade from a single site on the plasma membrane. Signaling can lead to sequestration of the virus particle to an endocytic hotspot from where it is internalized and can reorganise the actin cytoskeleton to form membrane ruffles and increase macropinocytosis. Signaling events have been studied extensively in the entry of SV40 and adenoviruses. The SV40 binds to GM1 and activates tyrosine kinases leading to endocytosis via the normally dormant caveolae (Pelkmans et al. [@CR68]). A second signal is induced in the caveosome to target SV40 to the ER (Pelkmans and Helenius [@CR67]). Adenovirus 2 binds and clusters integrins leading to activation of a variety of protein kinases, phosphatidylinositol-3-OH kinase (PI3K), and small GTPAses (Greber [@CR39]). The activation of focal adhesion kinase (FAK) impacts downstream molecules such as the ERK1/ERK2 mitogen-activated protein kinases. Major changes occur in cell surface dynamics, and in microtubule-mediated transport, which promote internalization, penetration and trafficking of the incoming virus. Activation of PI3K also results in the inhibition of apoptosis (an innate defense mechanism) and increased survival of host cells, which allows completion of the virus replication cycle and production of progeny virions. The human cytomegalovirus, a member of the family *Herpesviridae*, activates several signaling pathways through the interaction between its envelope glycoprotein B and the epidermal growth-factor receptor (Wang et al. [@CR95]). Poliovirus entry into HeLa cells requires tyrosine kinase activity (Brandenburg et al. [@CR13]), and it is likely that receptor-induced signals will prove to be important for infection in a variety of cell types. Virus induced signaling events thus affect host innate immune responses as well as cell survival and cell proliferation, all of which contribute positively to the the formation of new virions.

Perspectives {#Sec13}
============

Despite being simple in structure, viruses are remarkably versatile in their quest to infect and multiply. During infection, many cellular processes are subjected to manipulation by viruses. Therefore, unravelling viral pathogenesis and the spread of infection will require a detailed understanding of how viruses exploit the cellular machinery of the host. The first contact of a virus with the target cell, which includes binding and penetration of the plasma membrane is perhaps the most important decision point in the infection cycle. Our current understanding of the complex phenomenon of viral infection would not have been possible without technical developments in the field of light and electron microscopy. Viral entry events can now be analysed with increased spatial and temporal resolution. Single-virus imaging in live cells has readdressed and redefined many aspects of viral entry. These have also been complemented with excellent protein crystallography and ultrastructural studies. Future work will certainly see detailed characterization of novel endocytic pathways that have surfaced as viral entry portals. This will require high-resolution time-lapse imaging of the dynamics of multiple pathway components combined with computational image analysis. The plasticity observed in many cellular pathways, and the observation that viruses can make use of multiple internalization pathways suggests that direct inhibition of virus entry may not be feasible. The increased level of complexity demands investigations of viral infection at a systems biology level. Future challenges lie in getting a clear understanding of the link between viral entry and cellular signaling. This is necessary for the development of new antiviral drugs directed against cellular targets, such as signaling intermediates and/or regulators, rather than viral ones. Another important avenue will be to establish that the pathways observed in tissue culture experiments in vitro also operate in vivo during a productive infection. With the rapid development of in vivo imaging methods it should become possible to track virus particles in live tissues and animals. Thus, despite being sometimes lethal biological warriors, viruses continue to enthral us, as we use them as powerful tools to unravel cellular mysteries.

MK is supported by "Innovative Young Biotechnologist Award" from Department of Biotechnology, Government of India. We apologize to researchers whose work has not been directly cited due to limitations of space.
